argus

Epigral Limited

NSE: EPIGRALINE071N010165,350 Cr

Timeline

Time (IST)TypeMEventSrc
31 Aug, 05:47 pminvestor_meet1Epigral Limited informed the NSE about an investor/analyst plant visit scheduled for Thursday, 03.09.2026.nse
18 Aug, 06:39 pmEpigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on thursday, 20.08.2026nse
07 Aug, 04:56 pmEpigral Limited has informed the Exchange about participation in EMKAY Confluence 2026 on 12th August, 2026nse
30 Jul, 07:39 pmEpigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
30 Jul, 07:36 pmEpigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on Monday, 3rd August, 2026.nse
30 Jul, 07:31 pmEpigral Limited has informed the Exchange about Transcriptnse
29 Jul, 03:58 pmEpigral Limited has informed the Exchange about Copy of Newspaper Publication - Un-Audited Financial Results for the First Quarter ended 30.06.2026nse
27 Jul, 10:25 pmEpigral Limited has informed the Exchange about Link of Recordingnse
27 Jul, 10:22 pmEpigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
27 Jul, 02:16 pmEpigral Limited has informed the Exchange about Investor Presentationnse
27 Jul, 02:15 pmEpigral Limited has informed the Exchange regarding a press release dated July 27, 2026, titled "Press Release on Un-Audited Financial Results Q1 FY27".nse
27 Jul, 02:14 pmEpigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
27 Jul, 02:12 pmEpigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
27 Jul, 02:09 pmEpigral Ltd - 543332 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') - Outcome Of Board Meetingbse
27 Jul, 02:05 pmEpigral Limited has informed the Exchange about Adoption of new line(s) of businessnse
27 Jul, 02:00 pmEpigral Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.nse
27 Jul, 01:56 pmEpigral Ltd - 543332 - Board Meeting Outcome for Outcome Of Board Meeting Held On Monday, 27Th July, 2026 And Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The First Quarter Ended 30Th June, 2026.bse
27 Jul, 01:54 pmEpigral Ltd - 543332 - UNAUDITED FINANCIAL RESULTS - 30.06.2026bse
22 Jul, 02:45 pmEpigral Ltd - 543332 - Epigral Limited''s Reply To Clarification Sought With Reference To Movement In Volume.bse
22 Jul, 01:19 pmEpigral Limited has informed the Exchange about Conference Call on Monday, 27th July, 2026 to discuss Q1 FY27 Resultsnse
22 Jul, 12:04 pmEpigral Ltd - 543332 - Clarification sought from Epigral Ltdbse
22 Jul, 11:51 amEpigral Ltd - 543332 - Board Meeting Intimation for Intimation Of The Board Meeting Of Epigral Limited Scheduled To Be Held On Monday, 27Th July, 2026.bse
22 Jul, 10:54 amSignificant increase in volume has been observed in Epigral Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Epigral Limited has submitted their response.nse
21 Jul, 06:00 pmSignificant increase in volume has been observed in Epigral Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.nse
14 Jul, 07:10 pmEpigral Limited has informed the Exchange about Credit Rating- Revisionnse
14 Jul, 07:07 pmEpigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
07 Jul, 09:46 pmEpigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Acquisitionbse
07 Jul, 09:43 pmEpigral Limited has informed the Exchange about Incorporation of a Wholly owned Subsidiary namely "Epigral Advanced Materials Limited".nse
29 Jun, 02:52 pmEpigral Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
10 Jun, 06:26 pminvestor_meet1Epigral Limited informed about a one-on-one VC meeting with investor/analyst on June 16, 2026.nse
03 Jun, 05:30 pmEpigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
03 Jun, 05:27 pmEpigral Limited has informed the Exchange about Credit Ratingnse
26 May, 01:17 pmEpigral Ltd - 543332 - Compliances-Reg.24(A)-Annual Secretarial Compliancebse
18 May, 06:52 pmEpigral Limited has informed the Exchange about Copy of Newspaper Publication pertaining to 19th Annual General Meeting and Record Date for Dividend & E-Votingnse
18 May, 06:49 pmEpigral Limited has informed the Exchange about participation in Conference on 20th May, 2026nse
15 May, 06:03 pmEpigral Limited has submitted the BRSR of F.Y. 2025-26.nse
15 May, 06:01 pmEpigral Limited has submitted the Annual Report of F.Y. 2025-26.nse
15 May, 05:58 pmEpigral Ltd - 543332 - Reg. 34 (1) Annual Report.bse
14 May, 11:45 amEpigral Ltd - 543332 - Corporate Action-Board approves Dividendbse
14 May, 11:32 amEpigral Limited has informed the Exchange that Record date for the purpose of Dividend is 01-Jun-2026.nse
06 May, 01:30 pmEpigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
06 May, 01:27 pmEpigral Limited has informed the Exchange about Transcriptnse
03 May, 08:36 pmEpigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
03 May, 08:28 pmEpigral Limited has informed the Exchange about Link of Recordingnse
02 May, 04:18 pmEpigral Limited has informed the Exchange that Board of Directors at its meeting held on May 02, 2026, recommended Final Dividend of Rs. 5 per equity share.nse
02 May, 04:15 pmEpigral Ltd - 543332 - Corporate Action-Board approves Dividendbse
02 May, 04:11 pmEpigral Limited has informed the Exchange regarding a press release dated May 02, 2026, titled "Press Release on Audited Financial Results Q4 & FY2026".nse
02 May, 04:10 pmEpigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
02 May, 04:08 pmEpigral Limited has informed the Exchange about Investor Presentationnse
02 May, 04:06 pmEpigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Investor Presentationbse